- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 114,550 | 09.08.24 22:00:11 | +0,630 | +0,55% | 114,350 | 114,460 | 112,920 | 113,920 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 100,155 | 09.08.24 22:00:08 | +3,235 | +3,34% | 70,020 | 100,330 | 97,330 | 96,920 |
